You said it, it’s 6 month process. We are 6 months after
You said it, it’s 6 month process. We are 6 months after that.
I never said that a generic test strip would take 6 months. That was said on the other message board and migrated over here. There have been only two "generic" strips approved under the new FDA review team which took over in 2009. One was DECN's Genstrip and it took 23 months and 29 days. The other "generic" test strip took 23 months and 18 days. DECN's strip has done pretty well for itself, the other test strip has been a disaster for itself and the public. Subtracting out the government shutdown when nothing was reviewed by the FDA or even acknowledged, Genchoice has been in front of the FDA for 9 months. It will be approved, probably not soon enough for a NOBO like yourself because the approval won't happen on a Saturday or a Sunday, or the week before Thanksgiving. And one more thing, lack of company attention is not the cause of the delay. DECN employs the premier FDA Administrative law firm for in-vitro diagnostics. You work with a government regulatory agency, you hire the best lawyer you can afford, and take his advice totally. Not good enough or fast enough for the NOBOs, then too bad. that is just more proof that know it everything NOBOs should not be guiding or running a company.
A company in this business should also employ the best in-vitro consultant possible who can get into the sewers with FDA's comically unprepared staff and beat them with the science -- which is their real job, science not politics.
But here's a news flash. My recommendation to KB was, get the approval (it is actually called a clearance) and then immediately follow up with a TGB version of the same test strip without ever selling the "generic" version. Do something unique that would have much, much more value as a competitor. Abbott, which has its attention glued to its continuous glucose monitor would welcome a curve tweek for its 10 year old Freestyle without having to go through redevelopment cost. But you know what, doing that plan would not reflect the current share price is everything mindset and would cost the company some money.
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...
Continue Reading
Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...
Continue Reading
In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...
Continue Reading
AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...
Continue Reading
Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...
Continue Reading
Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...
Continue Reading
Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...
Continue Reading
Top 5 Most Recently Viewed Articles
Introduction to Q1 Investor Conferences This year has begun with a dynamic mix of geopolitical events that have positively impacted domestic energy-sector stocks. As we venture into 2026, the buzz around technological advancements, especially in artificial intelligence, is palpable. Investors are keenly awaiting insights and trends that will be presented at various...
Continue Reading
Overview of the November 2024 Podcast Metrics Triton Digital, a leading provider of technology and services in the digital audio and podcasting sector, has unveiled its reporting period for November 2024, covering from November 4 to December 1. This release comes from Triton’s Podcast Metrics measurement service, which offers critical insights into podcast performances...
Continue Reading
Overview of Treasury Bonds Auction Results In a recent auction, two significant treasury bonds were featured: RIKB 26 1015 and RIKB 38 0215. The auction process is a crucial activity in the finance world, presenting opportunities for investors to acquire bonds issued by the government. Each bond serves different funding needs, making it essential to assess their...
Continue Reading
DeepQure Welcomes New Global Vice President DeepQure, a trailblazer in innovative treatments for hypertension, has made a significant step forward with the recent appointment of Jason G. Jones as the Global Vice President of Clinical & Regulatory Affairs. This strategic move is expected to amplify DeepQure's ambitions as it seeks to redefine hypertension management with...
Continue Reading
Wave Life Sciences Presents Preclinical Findings at ObesityWeek 2025 Wave Life Sciences Ltd. (NASDAQ: WVE), a pioneering biotechnology firm, is excited to share breakthrough preclinical data on WVE-007, an innovative siRNA therapeutic targeting obesity. This research will be spotlighted in a poster presentation at ObesityWeek 2025, which features insights into how WVE-007...
Continue Reading